Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment.
about
ROCKs as immunomodulators of strokeContribution of blood platelets to vascular pathology in Alzheimer's diseaseNext-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis'Protein methionine oxidation augments reperfusion injury in acute ischemic strokePlatelets recognize brain-specific glycolipid structures, respond to neurovascular damage and promote neuroinflammationPlatelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapiesNatural Products for AntithrombosisDiscovery of novel GPVI receptor antagonists by structure-based repurposingAnother "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice.Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role.α2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke.Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion.Proteolysis of platelet receptors in humans and other species.Purinergic control of inflammation and thrombosis: Role of P2X1 receptorsCurcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCgamma2.Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes.Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.The Myosin II Inhibitor, Blebbistatin, Ameliorates FeCl3-induced Arterial Thrombosis via the GSK3β-NF-κB Pathway.Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study.Sustained reperfusion after blockade of glycoprotein-receptor-Ib in focal cerebral ischemia: an MRI study at 17.6 Tesla.von Willebrand factor: an emerging target in stroke therapy.The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model.SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature.Protein-protein interaction network and mechanism analysis in ischemic strokeSLAP/SLAP2 prevent excessive platelet (hem)ITAM signaling in thrombosis and ischemic stroke in mice.PET Demonstrates Functional Recovery after Treatment by Danhong Injection in a Rat Model of Cerebral Ischemic-Reperfusion Injury.Case-control study of platelet glycoprotein receptor Ib and IIb/IIIa expression in patients with acute and chronic cerebrovascular disease.Platelet glycoprotein Ibα is an important mediator of ischemic stroke in mice.Platelet-neutrophil interactions under thromboinflammatory conditionsA novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis.Extracellular chromatin is an important mediator of ischemic stroke in mice.Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation.Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation.Thrombosis recanalization by paeoniflorin through the upregulation of urokinase‑type plasminogen activator via the MAPK signaling pathway.Molecular imaging in traditional Chinese medicine therapy for neurological diseases.Synergistic Effect of AJW200, a von Willebrand Factor Neutralizing Antibody with Low Dose (0.9 mg/mg) Thrombolytic Therapy Following Embolic Stroke in RabbitsMolecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury.
P2860
Q26853214-D082FB70-41AD-44E1-A51D-CD22B7A792A2Q26861509-8B58B771-EA0C-488E-907A-62BE1B17588FQ26865345-C3661F2E-458B-4ED8-8DD7-8C2C5043C140Q27333918-3E3648F4-F4F3-4BA7-8D1C-4A7BC1D34662Q27334497-40BE76B3-7BBD-418D-929A-855411BC4821Q28068448-EC8708D8-1755-483F-846E-BD07F3DCA7ECQ28084934-324B6721-F57D-4005-813B-B1BF9FF0D4C5Q28540147-575BAED1-B1D4-4C74-BF10-84D9F9FBD0CAQ28543952-CFC4F1EE-A506-471F-A3D3-007C5DDC8241Q28590644-576D3991-18EA-4EE6-809F-E36932B9EC70Q30157042-BF4D132C-F4CA-4A7B-838D-E829708AF810Q30248728-9D2C10AA-3FA5-447E-9484-A7DC00D3588CQ30590837-4A8B8494-43B4-40DE-B9E5-B7A19ADCE6DAQ33389665-93B7AB8E-6FBD-4202-BD1E-20D0EA98AB7FQ33420664-2345FD8F-F4A2-414E-A013-E3EAC5DD14CAQ33531491-8A6FD6B5-0620-4F62-A06D-F5F24A940E21Q33602311-EEEF8A8D-FDA8-4512-8F39-10D0D6FD1618Q33640335-60F71521-8568-40E8-8303-48FA3D00D039Q33717776-6D5E5C8C-9BBC-46B3-9876-717E0856C5AFQ33768997-8BB3B83F-B00D-4CDB-BC9B-0E0221D1FECDQ33869531-C2E5A188-A63A-42E2-BBC2-16F37A6B4AC4Q33915674-ACDA72F8-8965-4BEC-A20D-1A609025E3D8Q33924274-EA0F8296-032D-4C2D-A725-F3350D236D3EQ34481558-527546A2-08C2-4B73-BA24-CCD3A71F8B03Q34540909-76756271-9FA9-4B10-90B6-83B7A5303F60Q34802412-C1035C98-2305-4F4C-BFB6-E0C26C7D2B3AQ35137885-71FD07AD-4FF7-41E6-ADFF-F9ED30383539Q35154663-536B73F5-22DD-4909-B67A-2821799F9365Q35232725-523B60EC-F1F8-4EBB-82C5-C171257A9AB4Q35779411-E2717BD4-05DA-4EE6-BCAE-03381ACBDB76Q35911764-92647F1E-A26C-42A2-9E22-2D8B9520B7E1Q36106323-27624D0A-7E1F-403C-A2C1-50AC3EE62F5DQ36387981-031E578E-304A-4744-B744-331EF0557FBAQ36528998-1FB98605-3B66-4EBC-B1E6-A1E43852894CQ36675073-AFA08622-BCAD-4CAC-848E-956E180062C9Q36931196-37A054D1-7595-4D20-90D7-203C8C68C1A4Q37270381-62C11F4B-D57E-49D6-BEB0-B31CA8D6EC14Q37284566-1682D301-D77D-45D9-A1E5-03D91EDA4206Q37340856-572D9609-9885-42E6-AF8A-A5BBF68AEA6BQ37729182-63888E82-083A-426E-A6D6-64D4CF6DA0E1
P2860
Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms of thromb ...... hts and targets for treatment.
@en
Molecular mechanisms of thromb ...... hts and targets for treatment.
@nl
type
label
Molecular mechanisms of thromb ...... hts and targets for treatment.
@en
Molecular mechanisms of thromb ...... hts and targets for treatment.
@nl
prefLabel
Molecular mechanisms of thromb ...... hts and targets for treatment.
@en
Molecular mechanisms of thromb ...... hts and targets for treatment.
@nl
P2093
P1433
P1476
Molecular mechanisms of thromb ...... hts and targets for treatment.
@en
P2093
Bernhard Nieswandt
Christoph Kleinschnitz
Guido Stoll
P304
P356
10.1182/BLOOD-2008-04-144758
P407
P577
2008-08-01T00:00:00Z